Annovis Bio, Inc. (ANVS)
NYSE: ANVS · IEX Real-Time Price · USD
9.28
+4.01 (76.09%)
At close: Jul 2, 2024, 4:00 PM
9.60
+0.32 (3.45%)
After-hours: Jul 2, 2024, 7:59 PM EDT
Annovis Bio Market Cap
Annovis Bio has a market cap or net worth of $103.67 million as of July 2, 2024. Its market cap has decreased by -20.38% in one year.
Market Cap
103.67M
Enterprise Value
100.53M
1-Year Change
-20.38%
Ranking
Category
Stock Price
$9.28
Market Cap Chart
Since January 29, 2020, Annovis Bio's market cap has increased from $56.80M to $103.67M, an increase of 82.52%. That is a compound annual growth rate of 14.57%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jul 1, 2024 | 58.90M | -69.31% |
| Dec 29, 2023 | 191.90M | 75.09% |
| Dec 30, 2022 | 109.60M | -23.03% |
| Dec 31, 2021 | 142.40M | 173.85% |
| Dec 31, 2020 | 52.00M | -8.45% |
| Jan 29, 2020 | 56.80M | - |
View and export this data all the way back to 2020.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Entera Bio | 65.90M |
| Benitec Biopharma | 65.48M |
| MDxHealth | 65.22M |
| MSP Recovery | 65.10M |
| Theratechnologies | 64.37M |
| Marinus Pharmaceuticals | 64.27M |
| AN2 Therapeutics | 64.13M |
| Carisma Therapeutics | 63.14M |